dichlororibofuranosylbenzimidazole has been researched along with Herpes Simplex in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Herpes Simplex: A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tigges, MA | 1 |
Koelle, D | 1 |
Hartog, K | 1 |
Sekulovich, RE | 1 |
Corey, L | 1 |
Burke, RL | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Herpes Simplex
Article | Year |
---|---|
Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.
Topics: Acyclovir; Antigens, Viral; CD8 Antigens; Clone Cells; Cycloheximide; Cytotoxicity, Immunologic; Dac | 1992 |